XPO1 Knockout HEK293 Cell Line

The choice depends on the experimental question. The Knockout line is the appropriate tool for asking whether XPO1 (CRM1) is required for nuclear export of specific cargo proteins, or for studying the consequences of disrupted leucine-rich NES-mediated export. Overexpression is useful for testing whether elevated XPO1 levels enhance export of specific substrates, or for studying cancer contexts where XPO1 upregulation contributes to tumor suppressor mislocalization. Important consideration: complete XPO1 knockout is generally lethal in most cell lines because many essential proteins depend on XPO1 for nuclear export. Partial loss-of-function or inducible systems may be more practically useful than complete KO for long-term studies. The EDITGENE Knockout line in HEK293 should be characterized for proliferation and viability before extended use. Rescue with wild-type or selinexor-resistant XPO1 mutants is particularly valuable for studying XPO1 inhibitor mechanisms.

Primary applications: • Nuclear export cargo analysis: subcellular fractionation followed by proteomics or Western blot for known NES-containing cargo proteins (p53, p21, FOXO, IκB) to identify export defects. • Selinexor mechanism studies: comparison of pharmacological XPO1 inhibition (selinexor, KPT-330) versus genetic knockout to distinguish on-target from off-target inhibitor effects. • Cancer phenotype assays: proliferation, apoptosis, and tumor suppressor localization studies relevant to XPO1's role in cancer biology. • Viability characterization: essential first step given XPO1's critical role in nuclear-cytoplasmic transport; many cell lines exhibit reduced viability following complete XPO1 loss. EDITGENE recommends this model for researchers investigating nuclear export biology, XPO1 inhibitor mechanisms, and cancer-relevant tumor suppressor mislocalization.

Yes, with important caveats specific to XPO1's essentiality: • Construct design: use a codon-modified XPO1 sequence with a C-terminal tag. NES-recognition by XPO1 occurs throughout the protein; large N-terminal tags should be avoided. • Viability considerations: complete XPO1 loss is poorly tolerated long-term; rescue experiments should be designed with timing controls that account for the limited window before viability declines without functional XPO1. • Selinexor-resistant mutant rescue: the C528S mutation confers resistance to selinexor and other SINE compounds. This rescue is particularly valuable for distinguishing on-target from off-target effects of XPO1 inhibitors. • Functional readout: rescue should restore nuclear export of NES-containing cargo (p53, FOXO, IκB) as measured by subcellular fractionation. HEK293 transduces efficiently with lentivirus; for rescue, lentiviral systems with rapid expression (CMV or EF1α promoters) are preferred given the time-limited window.